Start a ProjectMICRONEEDLE TECHNOLOGY
Dissolving microneedles are arrays of water-soluble or biodegradable microstructures designed to insert into the skin and dissolve after application, releasing the incorporated payload. Their performance depends on the combined design of the formulation, microneedle geometry, drug-loading strategy, mechanical strength and dissolution behavior.
Application → skin insertion → microneedle dissolution → payload release → patch or residual-backing removal. The defining feature is that moisture in the skin progressively hydrates and dissolves the microneedle matrix, enabling release of the incorporated payload.
Material selection and formulation development consider water-soluble polymers, polymer molecular weight, mechanical strength, dissolution behavior, moisture sensitivity, payload compatibility and formulation stability.
Payload may be distributed homogeneously through the needle, concentrated toward the tip, incorporated into a layered or multi-layer architecture, or paired with a separable backing layer. Layered or tip-loaded architectures are possible design options when a project requires greater control over payload localization, dose efficiency or release behavior. Selection depends on dose, stability, payload characteristics and manufacturing feasibility.
Needle geometry, matrix composition, residual moisture and backing design influence insertion strength, structural integrity and dissolution. Project-appropriate testing evaluates mechanical performance, skin insertion, dissolution time and release behavior.
Evaluation is selected for the development stage and may address content distribution, morphology, mechanical performance, insertion, dissolution, release and formulation stability. The objective is to support development decisions rather than to make a universal performance claim.
Payload stability, moisture and temperature sensitivity, mixing, filling, drying, demolding, backing, assembly and packaging are developed as one connected process. Scale-dependent risks and manufacturing feasibility are evaluated before process transfer.
Dissolving systems can be assessed for projects where a water-soluble or biodegradable matrix and payload release from the dissolving structure align with the target product profile. Dose, stability, payload characteristics, delivery requirements and manufacturing feasibility require project-specific evaluation.
CASMN team publications include dissolving microneedle studies involving peptides, proteins, vaccines, dermatology payloads and sustained-release structures. Two-layer and layered microneedle research is presented as a selected structural research example, not as the definition or standard form of dissolving microneedles.
DOI: 10.3390/pharmaceutics14061255 · View DOI ↗
Technical Review — Reviewed by: CASMN R&D Team · Last reviewed: August 2026.
No. Dose, stability, matrix compatibility, mechanical performance and delivery requirements must be evaluated together.
Layered or tip-concentrated designs can be evaluated as one structural option when appropriate for the payload and target product profile.
Non-confidential payload properties, target dose, intended use, available stability data and the target development stage are useful starting inputs.
Send your target product, payload, development stage and cooperation scope to our business development team.
Start a Project